Empresa Enanta Pharmaceuticals, Inc.
Acciones
ENTA
US29251M1062
Biotecnología e investigación médica
Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
12,37 USD | -0,88 % | -7,13 % | +31,46 % |
09/02 | ENANTA PHARMACEUTICALS, INC. : Oppenheimer se mantiene neutral. | ZM |
07/02 | Transcript : Enanta Pharmaceuticals, Inc., Q1 2024 Earnings Call, Feb 07, 2024 |
Resumen de negocios
Número de empleados: 145
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Small Molecule Drugs
100,0
%
| 86 | 100,0 % | 79 | 100,0 % | -8,07 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 86 | 100,0 % | 79 | 100,0 % | -8,07 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Jay Luly
CEO | Chief Executive Officer | 67 | 01/07/03 |
Paul Mellett
DFI | Director of Finance/CFO | 68 | 01/09/03 |
Chief Tech/Sci/R&D Officer | 50 | 08/08/22 | |
Yat Sun Or
CTO | Chief Tech/Sci/R&D Officer | 72 | 01/11/99 |
Jennifer Viera
IRC | Investor Relations Contact | - | 01/01/23 |
Brendan Luu
PRN | Corporate Officer/Principal | 49 | 26/01/21 |
Tara Kieffer
PRN | Corporate Officer/Principal | 46 | 08/12/20 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Mark Foletta
BRD | Director/Board Member | 63 | 29/06/20 |
Lesley Russell
BRD | Director/Board Member | 63 | 18/11/16 |
Bruce Carter
CHM | Chairman | 80 | 25/11/13 |
Jay Luly
CEO | Chief Executive Officer | 67 | 01/07/03 |
Terry Vance
BRD | Director/Board Member | 67 | 01/06/11 |
Yujiro Hata
BRD | Director/Board Member | 49 | 19/08/21 |
Director/Board Member | 64 | 13/09/17 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 21 155 983 | 19 865 549 ( 93,90 %) | 0 | 93,90 % |
Información de la empresa
Sector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+31,46 % | 262 M | |
+1,51 % | 42,75 mil M | |
+49,22 % | 41,61 mil M | |
+8,57 % | 41,34 mil M | |
-12,36 % | 26,59 mil M | |
+8,92 % | 25,49 mil M | |
-25,13 % | 18,12 mil M | |
+29,17 % | 12,24 mil M | |
-3,12 % | 11,76 mil M | |
+6,35 % | 11 mil M |
- Bolsa de valores
- Acciones
- Acción ENTA
- Empresa Enanta Pharmaceuticals, Inc.